Skip to main content

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Projects

Condensado de aire exhalado en sujetos normales y con patologia de la vía aérea: Variabilidad y valor diagnostico del pH y la concentración de Nox

IP: Fco. Javier Muñoz Gall
Collaborators: Mª Jesús Cruz Carmona
Funding agency: Instituto de Salud Carlos III
Funding: 7935
Reference: PI040656
Duration: 01/01/2005 - 28/11/2007

Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas.

IP: Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas.
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas., Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas., Odile Romero Santo-Tomas, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Albert Selva O'Callaghan, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 264070
Reference: C03/11
Duration: 01/01/2003 - 31/12/2005

El Potencial Nasal Diferencial (PND) como prueba diagnóstica de Fibrosis Quística.

IP: -
Collaborators: Antonio Álvarez Fernandez, Mª Jesús Cruz Carmona, SILVIA GARTNER TIZZANO
Funding agency: Instituto de Salud Carlos III
Funding: 36340
Reference: PI020161
Duration: 06/11/2002 - 06/11/2005

Niveles atmosféricos puntuales de soja en la ciudad de barcelona y su relación con los episodios de asma en individuos sensibilizados.

IP: -
Collaborators: Mª Jesús Cruz Carmona
Funding agency: Instituto de Salud Carlos III
Funding: 41650.14
Reference: 01/1386
Duration: 17/07/2001 - 31/12/2003

Related news

Dr. Miravitlles’ career was recognized during the 57th edition of the SEPAR National Congress held in Valencia.

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Albert Cored i Sala

Albert Cored i Sala

Tècnic/a de Laboratori
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
External Strategy Directorate
Read more
Izaskun Izagirre Urizar

Izaskun Izagirre Urizar

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Margarida Capell Maymo

Margarida Capell Maymo

Main researcher
Clinical Neuroimmunology
Read more
Sofia Schalka

Sofia Schalka

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.